Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 36.7%
Negative

Neutral
Zacks Investment Research
yesterday
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note
DaVita HealthCare (DVA) closed at $126.62 in the latest trading session, marking a +2.19% move from the prior day.
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note
Neutral
PRNewsWire
2 days ago
DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call
DENVER , Oct. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Wednesday, October 29, 2025, at 5:00 p.m. Eastern Time.
DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call
Negative
Zacks Investment Research
7 days ago
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $127.89, denoting a -2.4% move from the preceding trading day.
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
Negative
Zacks Investment Research
9 days ago
DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $128.14, denoting a -2.3% move from the preceding trading day.
DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade
Positive
Zacks Investment Research
12 days ago
DaVita HealthCare (DVA) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
DaVita HealthCare (DVA) is a Top-Ranked Growth Stock: Should You Buy?
Positive
Zacks Investment Research
13 days ago
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
Neutral
Zacks Investment Research
15 days ago
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts
In the latest trading session, DaVita HealthCare (DVA) closed at $132.87, marking a +1.75% move from the previous day.
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts
Positive
Zacks Investment Research
21 days ago
4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, ADUS and PNTG are well-poised to gain.
4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends
Positive
Zacks Investment Research
23 days ago
Should Value Investors Buy DaVita (DVA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy DaVita (DVA) Stock?
Neutral
Zacks Investment Research
28 days ago
DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, DaVita HealthCare (DVA) closed at $128, marking a -1.62% move from the previous day.
DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know